To The Moon

$Hims & Hers Health Inc.(HIMS)$ $Teladoc Health Inc.(TDOC)$ $LifeMD Inc.(LFMD)$ 🧭 Price Action at a Critical Fibonacci Zone

I’m fully convinced $HIMS is at one of its sharpest turning points since listing. The stock is back in the $43s, down 11 percent in the past week, 38 percent in three weeks, and 30 percent in three months. This brutal sell-off has brought the price into the 0.90 Fibonacci retracement zone. I’m convinced this isn’t about momentum anymore, it’s about survival of structure and narrative. If $44.50 holds, bulls can stage a reversal. If it fails, the $39.30 zone becomes the likely next target.

📊 Demand Zone at $41–$42 in Focus

I’m watching the $41–$42 demand zone closely. Multiple structures line up here: Elliott Wave count completion at (C) near $43.88, Fib confluence, and Keltner/Bollinger band compression. Historically, this is where mean reversion takes hold. I’m confident this is the area where bulls must make a stand. If they don’t, $39.30 gets exposed and the technical invalidation deepens.

⚖️ Regulatory Fallout and Legal Headwinds

I’m tactically focused on the legal and regulatory overlay. Novo Nordisk terminated its partnership with Hims & Hers on 23 June after allegations of illegitimate Wegovy sales. Stock collapsed 34.6 percent on the news. Now lawsuits are piling up, alleging securities fraud and deceptive statements that misled investors. To add further weight, the FTC has begun probing Hims for questionable advertising and subscription cancellation practices. I’m extremely cautious here; regulatory and legal risks can paralyse institutional conviction, regardless of near-term technical signals.

🏦 Institutional Flows and Short Pressure

I’m analysing flows beneath the surface. Whale activity shows 179 increases, 130 new positions, offset by 138 decreases and 55 closures. That paints a picture of selective conviction despite storm clouds. Shorts are heavy: 23.1 million shares, or 20.5 percent of float. I’m convinced this is a battleground of opposing forces: institutional nibbling on weakness versus short sellers pressing their advantage.

📈 Analyst Targets and Valuation Divergence

From a valuation lens, 13–14 analysts set average targets around $50.37–$50.66, implying 16 percent upside. The spread is wide: $28 to $85. Over half the coverage rates it a Hold, reflecting divided conviction. I’m confident that this divergence creates volatility: bulls will target $50–$55 if the floor holds, shorts will aim for sub-$40 if it cracks.

🧩 Technical Barriers and Momentum Triggers

Technically, $HIMS is below its 50 and 200-day MA cross (47.89 and 53.34). Bulls must reclaim $46.50 (daily bottom) and $49.96 (monthly top) to reverse momentum. Above that, targets reopen at $54.69 and $60.85, with longer extensions into $64.39 and $69.41. Until then, price remains structurally corrective and vulnerable. I’m confident that unless $46.50 is retaken, sellers remain in control.

🚀 Risk-Reward and Rebuild Scenarios

I’m preparing to add again if $44.50–$41 demand holds, but with an uncompromising stop. This is a dangerous setup until momentum confirms, but the asymmetry here is undeniable. Weekly formations suggest a possible rebuild toward $70 if defended, but failure brings a credibility crisis. I’m unequivocally focused on this as a credibility reset, not just a technical bounce.

This isn’t just a trade, it’s a transition point that will define whether Hims & Hers reclaims its telehealth growth story or remains locked in litigation and reputational risk. I’m here for the duel between conviction buyers and relentless shorts at this defining level.

Are you positioning around the $41–$44 demand zone as the line in the sand for $HIMS, or do you think we need to see capitulation toward $39 before a durable base forms?

📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀

Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀

@Tiger_comments @TigerPicks @TigerWire @TigerObserver @TigerPM @TigerStars @1PC @SPACE ROCKET